Erratum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation (Oncotarget. (2020) 11 (2137–2140) DOI: 10.18632/oncotarget.27598)
- Molina-Cerrillo, J.
- Alonso-Gordoa, T.
- Carrato, A.
- Grande, E.
ISSN: 1949-2553
Année de publication: 2022
Volumen: 13
Número: 1
Pages: 1245
Type: Erreur
